Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201
Industrial road
San Carlos, CA 94070Phone+1 310-794-9458Fax+1 310-825-3632
Summary
- Dr. David Ross is a pulmonologist in San Carlos, CA and is affiliated with Providence Saint John's Health Center. He received his medical degree from University of Southern California School of Medicine and has been in practice 38 years. He also speaks multiple languages, including Spanish. He specializes in critical care medicine, interventional pulmonology, and pleural disease and is experienced in pulmonary arterial hypertension and pulmonary transplantation. He has more than 90 publications and over 500 citings.
Education & Training
- Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 1983 - 1985
- Keck School of Medicine of the University of Southern CaliforniaClass of 1983
Certifications & Licensure
- CA State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation Start of enrollment: 2006 Jan 01
- Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Start of enrollment: 2007 Oct 01
Publications & Presentations
PubMed
- 4 citationsSignificance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.Rajeev Saggar, Paresh C. Giri, Chunqin Deng, Dana Johnson, Mary K McCloy
Pulmonary Circulation. 2021-05-02 - 28 citationsDonor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation.Kiran K. Khush, Iwijn De Vlaminck, Helen Luikart, David J. Ross, Mark R. Nicolls
ERJ Open Research. 2021-01-01 - 27 citationsPlasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data.David M. Sayah, S. Samuel Weigt, Allison Ramsey, Abbas Ardehali, Jeffrey A. Golden
Transplantation Direct. 2020-09-24
Press Mentions
- Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant RecipientsNovember 27th, 2024
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: